Steven Harr
Net worth: 30 M $ as of 31/05/2026
Net worth: 30 M $ as of 31/05/2026
Steven D. Harr founded Sana Biotechnology, Inc. and JW Therapeutics (Shanghai) Co., Ltd. Dr. Harr occupies the position of President, Chief Executive Officer & Director at Sana Biotechnology, Inc. and Treasurer & Director at X-Body, Inc. He is also on the board of JW Biotechnology (Shanghai) Co. Ltd. and Repertoire Immune Medicines, Inc. In the past he occupied the position of Research Analyst at Morgan Stanley & Co. LLC, Chief Financial Officer & Head-Development at Juno Therapeutics, Inc. and Director at JW Therapeutics (Shanghai) Co., Ltd. Dr. Harr received an undergraduate degree from College of the Holy Cross (Massachusetts) and a doctorate from The Johns Hopkins University School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 8,960,751 ( 3.46% ) | 30 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Founder | 13/07/2018 |
JW Biotechnology (Shanghai) Co. Ltd. | Director/Board Member | - |
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Director/Board Member | - |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Director/Board Member | 01/03/2020 |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | President | - |
| Companies | Position | End |
|---|---|---|
| LOXO ONCOLOGY INC | Director/Board Member | 15/02/2019 |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Founder | 25/09/2018 |
| JUNO THERAPEUTICS INC | Director of Finance/CFO | 01/03/2018 |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Chief Executive Officer | 01/04/2014 |
| ░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Sana Biotechnology, Inc.
Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions